Follow-up after colon cancer treatment in the Netherlands; a survey of patients, GPs, and colorectal surgeons  by Wind, J. et al.
Available online at www.sciencedirect.comEJSO 39 (2013) 837e843 www.ejso.comFollow-up after colon cancer treatment in the Netherlands; a survey of patients,
GPs, and colorectal surgeons
J. Wind a,*, L.A. Duineveld a, R.P. van der Heijden a, K.M. van Asselt a, W.A. Bemelman b,
H.C. van Weert a
aDepartment of Primary Care, Academic Medical Centre, Amsterdam, The Netherlands
bDepartment of Surgery, Academic Medical Centre, Amsterdam, The Netherlands
Accepted 25 April 2013
Available online 18 May 2013AbstractIntroduction: Follow-up to detect recurrence is an important feature of care after colon cancer treatment. Currently, follow-up visits are
surgeon-led with focus on recurrence. To date, there is increasing interest for general practitioners (GPs) providing this care, as GPs might
provide more holistic care.
The present study assessed how surgeons, GPs, and patients evaluate current surgeon-led colon cancer follow-up and to list their views
on possible future GP-led follow-up.
Methods: The study consists of a cross-sectional survey including colorectal surgeons, patients who participate or recently finished a follow-
up programme, and GPs in the Netherlands.
Results: Eighty-seven out of 191 GPs, 113 out of 238 surgeons, and 186 out of 243 patients responded. Patients are satisfied about current
surgeon-led follow-up, especially about recurrence detection and identification of physical problems (94% and 85% respectively). However,
only 56% and 49% of the patients were satisfied about the identification of psychological and social problems respectively. Only 16% of the
patients evaluated future GP-led follow-up positively. Regarding healthcare providers, surgeons were more positive compared to GPs; 49%
of the surgeons, and only 30% of the GPs evaluated future GP-led follow-up positively (P ¼ 0.002). Furthermore, several reservations and
principle requirements for GP-led follow-up were identified.
Discussion: The results suggest an unfavourable view among patients and healthcare providers, especially GPs, regarding a central role for
GPs in colon cancer follow-up. However, low satisfaction on psychosocial aspects in current follow-up points out a lack in care. Therefore,
the results provide a justification to explore future GP-led care further.
 2013 Elsevier Ltd. All rights reserved.
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It is expected that in 2015 more than 14.000 patients will
be diagnosed with colorectal cancer in the Netherlands.1,2
In more than three-quarter of newly diagnosed cases the
tumour is confined to a portion of the bowel and regional
lymph nodes enabling curative resection followed by adju-
vant chemotherapy when indicated. In spite of this intended
curative treatment approximately 30e40% of the patients* Corresponding author. Department of Primary Care AMC-UvA, Post-
box 22660, 1100 DD Amsterdam, The Netherlands. Tel.: þ31 649784744.
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http://dx.doi.org/10.1016/j.ejso.2013.04.001develop recurrent disease in the following years.1,3e5 After
curative treatment patients are included in a surgeon-led
follow-up programme with the focus on detection of recur-
rence and metachronous tumours in the Netherlands.
Nevertheless, patients have additional needs, including can-
cer and treatment related physical consequences, psycho-
logical and social problems, revalidation, and other
questions relating to functional impairments which are in
many cases insufficiently highlighted during these
visits.2,4,6e10
Concerning different follow-up strategies to detect
recurrent disease, intensive follow-up compared to minimal
follow-up results in a significant survival benefit favouring
intensive follow-up.4,11 However, there is a large variety in
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a number of different components including frequency and
type of clinical assessment and tests.4,11 Furthermore, there
is no consensus about the setting in which follow-up should
be conducted; should follow-up take place in the hospital
conducted by an oncological surgeon which is common,
non-evidence based, practice or is it possible in primary
care?
Few studies report on primary versus secondary care
follow-up of breast and colon cancer patients.12,13 These
studies show no statistically significant difference for qual-
ity of life, recurrence rate, and other outcomes. Further-
more, GP-led cancer follow-up might be more cost-
effective mainly due to a difference in organization and
physician costs.
It is therefore hypothesized that GP-led follow-up of pa-
tients with colon cancer seems safe with equal detection of
recurrences and subsequently equal number of resections of
recurrences with curative intent. GP-led follow-up might
also be more cost-effective. Furthermore, the care that
GPs offer might result in more attention for psychological
and social aspects increasing patients’ quality of life.
GP’s also argue that continuity of care might be better, as
they are often involved in the diagnostic process and palli-
ative care, but not in the chronic stadium of the disease.
Nevertheless, in the Netherlands it is unknown to what
extent surgeons, GPs, and patients with colon cancer are
willing to replace current surgeon-led by GP-led follow-
up. Therefore the aim of the present study is to assess
how surgeons, GPs, and patients evaluate current surgeon-
led and possible future GP-led follow-up.
Patients and methods
The study consists of a cross-sectional survey in the
period JuneeAugust 2012, including colorectal surgeons,
patients who participate in a follow-up programme or
recently finished their follow-up after they were operated
on for colonic cancer, and GPs. All GPs in the region of
the Academic Medical Centre Amsterdam and Almere
(n ¼ 191) were included. All Dutch hospitals were asked
which surgeon(s) operate on colonic malignancies and/or
are involved in follow-up. All these (colorectal)surgeons
(n ¼ 238) were included. The group of patients consists
of patients who participated in the LAFA trial (LAparos-
copy and/or FAst track multimodal management versus
standard care, ISRCTN:79588422), were alive in June
2012 and were willing to participate in future research
(n ¼ 243).14 Patients were treated in 9 Dutch hospitals (3
university hospitals and 6 teaching hospitals) and were
eligible if they were between 40 and 80 years of age,
had an American Society of Anaesthesiologists (ASA)
grade of I, II, or III, were to undergo elective segmental co-
lectomy for histologically confirmed adenocarcinoma, and
without evidence of metastatic disease. For the present
study ethics approval was obtained from the MedicalEthics Committee of the Academic Medical Centre in
Amsterdam.Survey instrumentsSeparate questionnaires were developed for the different
healthcare providers (i.e. colorectal surgeons and GPs) and
patients. Initially, question lists were developed by collect-
ing and extracting information from literature. The ques-
tions were than evaluated by a consensus process by four
of the authors followed by a critical evaluation by a psy-
chologist specialized in developing questionnaires. Finally,
the questionnaires were pilot tested on GPs (n ¼ 8), and
surgeons (n ¼ 5) at our institution and patients (n ¼ 7)
who had been operated on for a colon cancer. All the ques-
tionnaires included questions on socio-demographic char-
acteristics, how several aspects of current follow-up and
possible future GP-led follow-up are rated, questions on
possible inclusion and exclusion criteria for GP-led
follow-up (e.g. hereditary cancer, first follow-up period
versus later years with a lower recurrence rate). The ques-
tionnaires contained identical as well as specialty(patient)-
specific questions to facilitate comparisons across groups.
All questionnaires contained some open questions, most
questions had answer options according to the five-level
Likert-scale.
The patients were contacted with a postal survey, the
GPs and surgeons were approached by e-mail in which
they found a link to an online questionnaire (online survey
software by Survey Gizmo, www.surveygizmo.com).Data analysisParticipants were asked to react using a 5 point
Likert scale with 1 being “strongly disagree” and 5 being
“strongly agree”; 4 (“agree”) and 5 (“strongly agree”)
were considered as positive responses, 1 (“strongly
disagree”) and 2 (“disagree”) were considered as negative
responses. Descriptive statistical methods were used to
analyse the data by using SPSS v.18.0 package (SPSS, Chi-
cago, IL, USA). The Pearson Chi-square test was used to
explore univariate associations.
ResultsRespondentsIn Table 1 the characteristics of the respondents are
shown. For patients surgery was minimum 3 and maximum
7 years ago (mean 4.5  1.1) resulting in 118 (63%) pa-
tients who were in the first five years after surgery and still
included in the scheduled follow-up programme. Surgeons
had on average 101e150 patients who were curatively
treated for colon cancer in follow-up, GPs on average
1e5 patients. GPs practice size ranged between 330 and
5000 patients (mean 1854  699).
Table 1
Characteristics of the responding surgeons, GPs, and patients.
Surgeons GPs Patients
Response rate 113/238
(47.5%)
87/191 (45.5%) 186/243
(76.5%)
Mean age (range) 45.7
(33e65)
51.9 (32e64) 66.2
(43e80)
Male/Female ratio 96/17 45/42 109/77
Mean years of
experience (range)
11.3 (1e35) 20.2 (3e38) NA
SD: Standard Deviation; GPs: General Practitioners; NA: Not Applicable.
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led follow-up. Overall, patients are satisfied, especially
about recurrence detection and identification of physical
problems, also patients had trust in their surgeon in
adequate recurrence detection. Only 12% of the patients
answered that they experienced problems that weren’t ad-
dressed during the follow-up visits and 3% of the patients
felt that they weren’t taken seriously. However, patients’
satisfaction on identification of psychological and social
problems was much less and only about a third of the pa-
tients trusted the surgeon in adequate identification of so-
cial problems. Seventy-seven percent of patients answered
that enough time could be spent on physical problems but
this decreased to 37% concerning social problems.
Current involvement in cancer care of the GP is limited,
only 18% of the patients visited the GP during the treat-
ment phase and 11% during the follow-up phase with can-
cer or treatment related problems (most frequently with
diarrhoea or dietary problems). To assess patients’ opinion
on future GP-led follow-up patients were asked if the GP
could perform follow-up for future patients. Despite the
fact that patients gave their GP a high grade on average
(7.7  1.5, on a 10-point scale), only 16% responded posi-
tively (Table 3). If patients’ probability of recurrence is low,
36% is in favour of GP-led follow-up declining to 8% if
there is a high probability. In the open answer fields 73%
of the patients made remarks on the lack of specific knowl-
edge and of diagnostic facilities such as ultrasonography
which patients thought were not accessible for GPs. Pa-
tients trust in the GP in detection of recurrence, identifica-
tion and treatment of cancer related physical, psychologicalTable 2
Patients’ evaluation of current surgeon-led follow-up.
% patients rating issue as important
(mean likert scalea, 95% CI)
Detection of recurrence 100 (4.87, 4.82e4.92)
Identification of physical problems 98.4 (4.64, 4.57e4.72)
Identification of psychological problems 82.8 (4.20, 4.09e4.32)
Identification of social problems 75.5 (4.11, 3.98e4.23)
CI: Confidence Interval.
a Participants were asked to react using a 5 point Likert scale with 1 being “s
b The sum of patients who answered with 4 (“agree”) and 5 (“strongly agree”and social problems is shown in Table 4. The fact that the
GP is familiar with the patients’ history, knows the family,
or that in most cases the GPs office is nearer were not
important to patients. About half of the patients answered
that they would go earlier to the GP with physical problems
than to the surgeon but only a third of the patients would
address social problems earlier to the GP. The influence
of patients age, grading of their GP (0e10), yearly number
of consultations, number of years enlisted to their GP, the
presence of co-morbidity, the occurrence of postoperative
complications, Dukes stage, and if the patient was still
included in the first five years of follow-up on patients’
opinion if the GP could perform future follow-up and pa-
tients trust in their GP to detect recurrence was tested in
univariate analysis using cross-tabs. Only grading of their
GP had a significant influence. Six percent of the patients
grading their GP as inadequate had the opinion that the
GP could perform future follow-up versus 18% of patients
grading their GP as adequate ( p ¼ 0.003). None of the pa-
tients grading their GP as inadequate had trust recurrence
detection versus 32% of patients grading their GP as
adequate ( p < 0.001).Surgeons’ and GPs’ point of viewThe majority of both surgeons and GPs address five
years follow-up as an important feature of colon cancer
care. Considering current surgeon-led follow-up, a minority
of GPs is satisfied with recurrence detection, the identifica-
tion and treatment of physical, psychological and social
problems. Also, GPs don’t feel involved partly due to a
lack of communication. Nevertheless, GPs think that 63%
of the patients are satisfied with current follow-up. Also
surgeons, are satisfied and they believe that patients are
satisfied as well. Despite the high satisfaction, 74% of the
surgeons experience lack of time during these visits, result-
ing in less attention for psychological and social issues.
Moreover, over 40% of the surgeons are confronted with
physical and psychosocial problems beyond their field of
experience. The majority of both surgeons and GPs
answered that GPs could spend more time on psychological
and social problems. Also, both answered that patients
would visit the GP earlier with these kinds of problems.
GPs are statistically more pronounced in their opinionb % patients satisfiedb
(mean likert scalea, 95% CI)
% patient with trust in the surgeonb
(mean likert scalea, 95% CI)
93.5 (4.53, 4.41e4.64) 92.4 (4.47, 4.36e4.59)
85.4 (4.19, 4.06e4.33) 73.2 (4.05, 3.90e4.20)
56.4 (3.76, 3.62e3.90) 42 (3.49, 3.35e3.63)
49.2 (3.61, 3.47e3.75) 34.1 (3.37, 3.24e3.51)
trongly disagree” and 5 being “strongly agree”.
).
Table 3
Surgeons’, GPs’ and patients’ opinion on future GP-led colon cancer follow-up.
% surgeons (strongly)
agreeb (mean likert
scalea, 95% CI)
% GPs (strongly)
agreeb (mean likert
scalea, 95% CI)
p-Value comparison
surgeons’ versus
GPs’ opinion
% patients (strongly)
agreeb (mean likert
scalea, 95% CI)
p-Value comparison
physicians’ (surgeons
and GPs) versus
patients’ opinion
Future GP-led follow-up
of colonic cancer
49.1 (3.18, 2.94e3.43) 30.1 (2.87, 2.67e3.08) 0.002 16.2 (2.38, 2.21e2.54) P < 0.001
Future GP-led follow-up
of low riskc patients
50.4 (3.17, 2.94e3.41) 34.1 (2.99, 2.77e3.21) 0.004 35.5 (2.83, 2.65e3.02) 0.005
Future GP-led follow-up
of high riskd patients
18.2 (2.26, 2.06e2.46) 19.1 (2.28, 2.06e2.51) 0.933 7.6 (2.11, 1.98e2.24) 0.014
Follow-up of low riskc
patients first 2 years
surgeon-led followed
by GP-led follow-up
53.1 (3.28, 3.08e3.48) 50.6 (3.29, 3.09e3.50) 0.465 NA
Follow-up of high riskd
patients first 2 years
surgeon-led followed
by GP-led follow-up
41.4 (3.01, 2.79e3.23) 36.4 (2.81, 2.56e3.06) 0.675 NA
Future GP-led follow-up
of hereditary
colonic cancer
10 (2.17, 2.01e2.32) 21.1 (2.41, 2.17e2.66) 0.123 NA
NA: Not Assessed; CI: Confidence Interval; GP: General Practitioner.
a Participants were asked to react using a 5 point Likert scale with 1 being “strongly disagree” and 5 being “strongly agree”.
b The sum of respondents who answered with 4 (“agree”) and 5 (“strongly agree”).
c Dukes A.
d Dukes B2 and C.
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opinion as shown above ( p < 0.001).
Considering surgeons’ and GPs’ opinion on future GP-
led colon cancer follow-up surgeons are statistically signif-
icant more positive; 49% of the surgeons and 30% of the
GPs evaluated future GP-led follow-up positively
(P ¼ 0.002, Table 3). Considering patients with a high
risk of recurrence only 18% of the surgeons and 19% of
the GPs are positive. When the follow-up is the first 2 yearsTable 4
Surgeons’, GPs’ and patients’ opinion on the capability of GPs to detect recurren
psychological and social problems.
% surgeonsb stating
they had trust in the
capability of the
GP (mean likert
scalea, 95% CI)
% GPsb stating
had trust in thei
own capability
(mean likert
scalea, 95% CI)
The capability to detect recurrent
disease
22.0 (2.73, 2.56e2.90) 30.1 (2.90, 2.70
The capability to identify and treat
(including referral) cancer related
physical problems
59.1 (3.43, 3.27e3.59) 55.8 (3.45, 3.27
The capability to identify and treat
(including referral)
psychological problems
93.8 (4.08, 3.98e4.19) 95.3 (4.14, 4.02
The capability to identify and treat
(including referral) social
problems
96.5 (4.19, 4.09e4.28) 94.1 (4.10, 3.98
a Participants were asked to react using a 5 point Likert scale with 1 being “s
b The sum of respondents who answered with 4 (“agree”) and 5 (“strongly agsurgeon-led followed by GP-led follow-up this increases.
Surgeons and GPs share their opinion on the capability of
GPs to detect recurrent disease, to identify and treat
(including referral) cancer related physical, psychological
and social problems as shown in Table 4. About half of
the surgeons and two-third of the GPs stated that GP-led
follow-up will reduce costs. Nevertheless, also two-third
of the GPs requires additional financing as a condition
before implementation. Finally, Table 5 shows GPst disease, to identify and treat (including referral) cancer related physical,
they
r
p-value comparison
surgeons’ versus
GPs’ opinion
% patientsb stating
they had trust in the
capability of the GP
(mean likert scalea,
95% CI)
p-value
comparison
physicians’
(surgeons and
GPs) versus
patients’ opinion
e3.10) 0.679 26.3 (2.77, 2.60e2.94) P < 0.001
e3.63) 0.522 41.8 (3.23, 3.07e3.40) P < 0.001
e4.25) 0.909 41.2 (3.26, 3.11e3.40) P < 0.001
e4.22) 0.465 34.6 (3.13, 2.99e3.28) P < 0.001
trongly disagree” and 5 being “strongly agree”.
ree”).
Table 5
Education modalities supporting GPs in future follow-up.
Modality % of GPs rating
modality as useful
Individual care plan available after discharge 66
Education courses regarding follow-up 60
A specific guideline 47
Pop-ups in electronic patient file at the GPs office 36
Website with information 34
Specialist and GP shared electronic patient file 31
Pamphlets on follow-up 12
None modalities necessary 2
GPs; General Practitioners.
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tion modalities (two third stated they do) which modalities
are needed.
Discussion
Based on the questionnaires it appears that both patients
and surgeons are satisfied with current surgeon-led colon
cancer follow-up especially regarding recurrence detection
and the identification and treatment of physical problems.
Patients also have the opinion that follow-up after a colon
cancer is a specialist task which cannot be executed as
well by a GP as by a surgeon. Only when the probability
of the cancer returning is very low, a third of the patients
states that the GP can take over follow-up.Previous researchOthers have published the same figures of high satisfac-
tion with hospital follow-up and patients concerns about
seeing their GP for cancer follow-up.15,16 Barriers that
are described include lack of expertise, limited involvement
with original cancer care, and lack of continuity.
In the present study surgeons were a bit more positive
compared to GPs; half of the surgeons and a third of the
GPs rate future GP-led follow-up positively and only a fifth
of the surgeons and a third of the GPs rate the GP capable
of adequate recurrence detection.
A large survey in the US among GPs and oncologists
concerning breast and colon cancer showed similar re-
sults.17 Among GPs a shared care model was preferred
by 38% while only 10% preferred a GP-led model. In
contrast oncologists most often preferred an oncologist-
led model and only 2% a GP-led model. A majority of
GPs but a minority of the oncologists agreed that GPs
have the necessary skills to provide follow-up. In a Cana-
dian survey also the minority of GPs was willing to assume
exclusive responsibility for routine follow-up immediately
after treatment. However, yet after 2.6 years GPs were
willing to assume exclusive responsibility.18
As previously pointed out by others, the results of the
present study show that lack of receptiveness to more GPinvolvement among patients and healthcare providers could
compromise efforts to promote shared care or GP-led
models.17 Another barrier identified in the present study
is that GPs (and also surgeons and patients) are uncertain
about the GPs’ skills to detect recurrent disease and treat
cancer or treatment related physical problems.
Several studies report on reservations and principle re-
quirements for GP-led follow-up.17e19 Reservations
include lack of knowledge, work burden, lack of guidelines,
and delays of re-referrals to specialists. Principle require-
ments include a patient-specific letter from the specialist,
printed guidelines, seminars, expedited routes of re-
referral and expedited access to investigations for suspected
recurrence. So, GPs require guidelines and education to
enhance their knowledge and confidence. Furthermore,
proper arrangements should be made on communication
(e.g. shared patient file, individual care plans, patient-
specific letter), routes for referral, and prompt access to
investigations.
To date there is some evidence on the outcome of can-
cer follow-up in primary care suggesting at least equal out-
comes. In a systematic review by Lewis et al. primary
versus secondary care follow-up of breast and colon can-
cer was assessed including 3 randomized trials (2 breast,
1 colon cancer) reporting on a total of 1467 patients
with a follow-up ranging between 18 months and 3.5
years. There was no difference for patient wellbeing, qual-
ity of life, recurrence rate, survival, recurrence-related
serious clinical events, diagnostic delay, or patient satis-
faction. GP-led breast cancer follow-up was less expensive
mainly due to a difference in physician costs (£ 130).12
The only study included in the review reporting on colon
cancer by Wattchow et al. consisted of a multi-centre, ran-
domized trial conducted in Australia including 203 pa-
tients.13 At 12 and 24 months there were no differences
in quality of life, anxiety, depression, or patient satisfac-
tion. General practitioners ordered more FOBTs than sur-
geons, whereas more colonoscopies, and ultrasounds were
undertaken in the surgeon-led group. Therefore, GP-led
follow-up might be even effective but cheaper compared
to surgeon-led follow-up. Currently, large randomized
controlled trials are undertaken in Norway and the UK
(FACS trial) to evaluated GP-led follow-up compared to
hospital follow-up.20,21Psychological and social well-beingNevertheless, follow-up for cancer recurrence is not the
only requirement during the years after initial treatment;
additional points of interest are physical symptoms, due
to the tumour and/or its treatment as well as psychosocial
needs.4,7 Previous research showed that psychosocial care
is important to patients but these needs were not always
met in secondary care.8 All cancer patients experience
distress and it is evident that part of the cancer survivors
experience chronically comprised psychological health or
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covery.6 Up to a third will develop major depressive or anx-
iety disorder. In addition, patients must adept to changes to
their domestic and working lives, with some patients expe-
riencing problems with daily living, finances and employ-
ment.22 These patients stand to benefit from more
intensive psychological and social care. However, studies
suggest that only a small number of distressed patients
are identified and treated in secondary care due to a combi-
nation of factors including under reporting of psychosocial
problems, a lack of recognition of psychosocial morbidity,
and a lack of expertise of psychological services and possi-
bilities of psychosocial support.22,23 The same is shown in
the present study as patients were less satisfied with psy-
chosocial care, and also the majority of surgeons stated
that psychosocial problems received less attention due to
lack of time and experience. Therefore, in future GP-led
follow-up psychosocial support should receive attention
and a pro-active approach is mandatory. In the current study
both surgeons and GPs rate the skills and available time of
GPs to tackle psychosocial problems high. Also in other
studies GPs believed that they are better able to provide
psychosocial care.17,18 However, in the present study only
a third of the patients would address social problems earlier
to the GP than to the surgeon and the patients’ trust in the
GP concerning psychosocial issues isn’t greater compared
to the trust in the surgeon. In future care specific social
and psychological problems should specifically be targeted
for identification and preventive and intervention efforts.6Strengths and limitationsThe strength of the present study is that all major partic-
ipants in colon cancer follow-up were asked on their
opinion on both current and future follow-up including a
wide range of topics such as detection of recurrence but
also psychosocial issues. Furthermore, the group of patients
was fairly large including both patients currently taking
part in a follow-up schedule and patients who recently
finished their follow-up.
However, the response rate of the surgeons and GPs was
less than fifty percent and we were not able to gather data
on the non-responders. The way this might have influenced
our results in not clear.
A question remaining is whether patients are able to
assess what GP-led follow-up would be like. In regard to
this a shortcoming of the questionnaire was identified as
it should have been clearer to patients that in future GP-
led follow-up the scheduled examinations are similar to
surgeon-led follow-up as in the open text boxes many pa-
tients made remarks that their GP had no access to ultraso-
nography, endoscopy, and CEA monitoring. This might be
in part responsible for the low rate of patients who are pos-
itive on future GP-led follow-up. Another weakness of this
study is that for several remarkable outcomes such as the
surprisingly low rating of current surgeon-led follow-upby GPs the questionnaire lacked additional questions to
clarify these outcomes.ConclusionIn conclusion, the results of the present study suggest an
unfavourable view among patients and healthcare pro-
viders, especially GPs regarding a central role for GPs in
colon cancer follow-up. A shared-care model was better
supported. However, the low satisfaction on psychosocial
aspects in current follow-up and reservations and require-
ments for future GP-led follow-up that were identified in
the present study provide the justification to explore future
GP-led follow-up further.
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